Raymond James Financial Services Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.41M | Buy |
20,156
+344
| +2% | +$24K | ﹤0.01% | 1931 |
|
|
2024
Q2 | $1.28M | Buy |
19,812
+845
| +4% | +$54.8K | ﹤0.01% | 1922 |
|
|
2024
Q1 | $1.23M | Buy |
18,967
+2,118
| +13% | +$137K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $1.11M | Sell |
16,849
-398
| -2% | -$26.2K | ﹤0.01% | 1911 |
|
|
2023
Q3 | $984K | Sell |
17,247
-125
| -0.7% | -$7.13K | ﹤0.01% | 1918 |
|
|
2023
Q2 | $1.06M | Buy |
17,372
+943
| +6% | +$57.8K | ﹤0.01% | 1895 |
|
|
2023
Q1 | $1.03M | Buy |
16,429
+382
| +2% | +$24K | ﹤0.01% | 1877 |
|
|
2022
Q4 | $1.02M | Buy |
16,047
+1,558
| +11% | +$98.9K | ﹤0.01% | 1828 |
|
|
2022
Q3 | $854K | Buy |
14,489
+10,039
| +226% | +$592K | ﹤0.01% | 1910 |
|
|
2022
Q2 | $257K | Sell |
4,450
-1,337
| -23% | -$77.2K | ﹤0.01% | 2692 |
|
|
2022
Q1 | $359K | Sell |
5,787
-1,018
| -15% | -$63.2K | ﹤0.01% | 2577 |
|
|
2021
Q4 | $485K | Sell |
6,805
-555
| -8% | -$39.6K | ﹤0.01% | 2382 |
|
|
2021
Q3 | $551K | Buy |
7,360
+651
| +10% | +$48.7K | ﹤0.01% | 2307 |
|
|
2021
Q2 | $519K | Buy |
6,709
+387
| +6% | +$29.9K | ﹤0.01% | 2342 |
|
|
2021
Q1 | $467K | Sell |
6,322
-91
| -1% | -$6.72K | ﹤0.01% | 2334 |
|
|
2020
Q4 | $450K | Sell |
6,413
-900
| -12% | -$63.2K | ﹤0.01% | 2202 |
|
|
2020
Q3 | $414K | Sell |
7,313
-2,519
| -26% | -$143K | ﹤0.01% | 2088 |
|
|
2020
Q2 | $573K | Sell |
9,832
-1,560
| -14% | -$90.9K | ﹤0.01% | 1823 |
|
|
2020
Q1 | $530K | Buy |
11,392
+3,333
| +41% | +$155K | ﹤0.01% | 1509 |
|
|
2019
Q4 | $450K | Sell |
8,059
-1,800
| -18% | -$101K | ﹤0.01% | 2055 |
|
|
2019
Q3 | $467K | Sell |
9,859
-225
| -2% | -$10.7K | ﹤0.01% | 1947 |
|
|
2019
Q2 | $540K | Sell |
10,084
-1,104
| -10% | -$59.1K | ﹤0.01% | 1877 |
|
|
2019
Q1 | $617K | Sell |
11,188
-680
| -6% | -$37.5K | ﹤0.01% | 1750 |
|
|
2018
Q4 | $559K | Buy |
11,868
+765
| +7% | +$36K | ﹤0.01% | 1605 |
|
|
2018
Q3 | $660K | Buy |
11,103
+202
| +2% | +$12K | ﹤0.01% | 1722 |
|
|
2018
Q2 | $596K | Sell |
10,901
-1,850
| -15% | -$101K | ﹤0.01% | 1757 |
|
|
2018
Q1 | $628K | Sell |
12,751
-3,523
| -22% | -$174K | ﹤0.01% | 1581 |
|
|
2017
Q4 | $767K | Sell |
16,274
-11,596
| -42% | -$547K | ﹤0.01% | 1464 |
|
|
2017
Q3 | $1.39M | Buy |
27,870
+6,549
| +31% | +$327K | 0.01% | 1101 |
|
|
2017
Q2 | $974K | Buy |
21,321
+14,750
| +224% | +$674K | 0.01% | 1285 |
|
|
2017
Q1 | $278K | Sell |
6,571
-253
| -4% | -$10.7K | ﹤0.01% | 1943 |
|
|
2016
Q4 | $265K | Buy |
6,824
+147
| +2% | +$5.71K | ﹤0.01% | 1870 |
|
|
2016
Q3 | $280K | Buy |
6,677
+30
| +0.5% | +$1.26K | ﹤0.01% | 1826 |
|
|
2016
Q2 | $246K | Buy |
6,647
+470
| +8% | +$17.4K | ﹤0.01% | 1843 |
|
|
2016
Q1 | $236K | Sell |
6,177
-4,150
| -40% | -$159K | ﹤0.01% | 1676 |
|
|
2015
Q4 | $522K | Sell |
10,327
-854
| -8% | -$43.2K | 0.01% | 1181 |
|
|
2015
Q3 | $511K | Buy |
+11,181
| New | +$511K | 0.01% | 1038 |
|